NCT01673620

A Study to Evaluate the Safety of Combination Montelukast/Loratadine in Mexican Participants With Allergic Rhinitis (MK-0476A-484)

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety of Combination Montelukast/Loratadine (MK-0476A) in Mexican Patients With Allergic Rhinitis

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 69 (actual)
• Sponsor: Organon and Co · Industry
• Sex: All
• Age: 15 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess the safety and tolerability of montelukast 10 mg/loratadine 10 mg versus placebo in Mexican participants with allergic rhinitis.

Conditions

• Allergic Rhinitis

Interventions

Type	Name	Description
DRUG	Montelukast 10 mg/loratadine 10 mg	Montelukast 10 mg/loratadine 10 mg tablet administered once daily
DRUG	Placebo	Matching placebo tablet administered once daily

Timeline

• Start date: 2012-07-04
• Primary completion: 2012-10-10
• Completion: 2012-10-10
• First posted: 2012-08-28
• Last updated: 2024-09-04
• Results posted: 2014-11-14